Therapeutic areas in focus Volume 74 Autumn 2022: Welcome to issue 74 of Pharmafile! This issue covers topics from neurology to rare diseases and cardiovascular and metabolic health, as well as a brand new news section

Therapeutic areas in focus Volume 74 Autumn 2022, cover, neurology, rare diseases, cardiovascular


Pharmafile

PrimeVigilance: Full Global Pharmacovigilance Services

PrimeVigilance

Therapeutic Areas in Focus: Issue 74 covers topics such as neurology, rare diseases and cardiovascular and metabolic health, as well as debuting a news section.

Therapeutic Areas in Focus: news, neurology, rare diseases, cardiovascular and metabolic health

Editor’s letter

Samedan Ltd

Bio-Rad and Qiagen plan to merge in a deal potentially worth over $10bn

Merger planned between Bio-Rad and Qiagen - Pharmafile News

Merger planned between Bio-Rad and Qiagen

Aptar Pharma completes first stage of its global expansion programme, costing approximately $180m

Aptar Pharma completes first phase of global expansion

Johnson & Johnson is planning to acquire Abiomed for $17bn 


Johnson & Johnson to buy Abiomed for $17bn

Merger completed between Norstella and Citeline to create $5bn pharma tech firm


Norstella and Citeline merge to create $5bn pharma tech firm

DJS Antibodies acquired by AbbVie for $255m 


Oxford biotech purchased by AbbVie for $255m

Gilead Sciences and Macrogenics partner for bispecific antibody development


Gilead and MacroGenics partner for bispecific antibody development

FDA approves Nevro Corporation's new AI device to treat chronic pain 

AI device to treat chronic pain approved by FDA

CAR T cell therapy for B cell lymphoma approved by European Commission 

EC approves CAR T cell therapy for B cell lymphoma

FDA approves AstraZeneca's liver cancer treatment 

AstraZeneca’s liver cancer treatment gets FDA approval

FDA approves GSK's whooping cough vaccine, Boostrix, for use in pregnant patients 

FDA clears GSK’s Boostrix for use in pregnancy

FDA approves Furosemide to treat patients with chronic heart failure

news, approvals, FDA, chronic heart failure

Furosemide approved by FDA for patients with chronic heart failure

New but controversial ALS drug, Relyviro, approved by FDA

Controversial ALS drug approved by FDA

Pharma company, Merck, is under official investigation in France

Merck under official investigation in France

FDA recalls two blood pressure pills due to risk that they may cause cancer

FDA announces recall of two blood pressure pills over cancer risk

US pharmacies agree to paying $10bn in opioid litigation settlement following opioid crisis


US pharmacies agree to $10bn opioid litigation settlement

New pill which may halt cancer is given to first patient in a trial 

Potentially cancer-stopping pill given to first patient

New cancer vaccine may be available by 2030 


Cancer vaccine may be available by 2030

New digital technology and AI can further neurological research and clinical trials

AI, digital technology, neurology, clinical trials


AI and digital tech open up new frontiers in neurology research

Clinical trials in neurological conditions such as MS have been impacted by COVID-19, but how can they improve in the future?


clinical trials, neurology, MS, COVID-19


Unmet needs in clinical tr ials for neurological conditions

Vasopharm tells Pharmafile about the significance of TBIs and the need to treat them in the acute phase


neurology, TBIs, brain injury, treatment 


The importance of treating TBIs early

Pharmafile speaks to UCB: UCB discuss the challenges facing neurology and how these can be overcome


Pharmafile speaks to UCB neurology, treatment, patients


Looking to the future of neurology

The rare disease treatment market has been rapidly changing and receive deserved recognition


Helping rare diseases emerge from the shadows to take centre stage

Pharmarole

Pharmafile speaks to Chiesi Group: Chiesi Group tells Pharmafile about the challenges facing rare disease research and their hopes for the future of this area


Pharmafile speaks to Chiesi Group rare diseases, treatment options, challenges


The changing landscape of rare disease research

Patient advocacy organisations can form an effective partnership between clinical trials and patients for more efficient trials 


The power of partnership: Collaborating with PAOs for better clinical research

Aaron Bean at Veeva explores the challenges of rare diseases: With up to 30 million people in EU living with rare diseases, Veeva discusses the challenges facing these rare diseases


Aaron Bean at Veeva explores the challenges of rare diseases rare diseases, treatment, HCPs, data


Rising to the unique challenges of rare diseases

The challenge of cardiovascular disease: Daiichi Sankyo tells Pharmafile about their role in improving access to cardiovascular treatments and the prevention of CVD


cardiovascular, CVD, treatments, prevention


Addressing inequalities in access to medicines in a post-COVID world

What treatments can be used for diuretic-resistant congestion in chronic heart failure, and what challenges face them?


Chronic heart failure, diuretics, congestion


AI ushers in new ideas for neurology

Rare diseases and patient groups

Advances in cardiology

PrimeVigilance